Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Effect of LY2062430 on the Progression of Alzheimer's Disease (EXPEDITION2)

This study has been completed.
Information provided by (Responsible Party):
Eli Lilly and Company Identifier:
First received: May 18, 2009
Last updated: December 11, 2012
Last verified: December 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2012
  Primary Completion Date: June 2012 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: September 18, 2012